Malaria News and Research RSS Feed - Malaria News and Research Twitter

Malaria is a mosquito-borne disease caused by a parasite called Plasmodium - when infected mosquitoes bite the human body, the parasites multiply in the liver, and then infect red blood cells. Even though this potentially fatal disease can be prevented and cured, each year 350-500 million cases of malaria still occur worldwide, and over one million people die, most of them young children in Africa south of the Sahara, where one in every five (20%) childhood deaths is due to the effects of the disease.

Malaria is so common in Africa because a lack of resources and political instability have prevented the building of solid malaria control programs. Experts say an African child has on average between 1.6 and 5.4 episodes of malaria fever each year and according to the World Health Organization (WHO) as many as half of the world's population are at risk of malaria mainly in the world's poorest and most vulnerable countries and every 30 seconds a child dies from malaria.
LSTM emerges high on academic rankings

LSTM emerges high on academic rankings

Liverpool School of Tropical Medicine is emerging high on the academic rankings under its own name following the designation of Higher Education Institutions status earlier in 2013. [More]
New analysis finds global improvements in life expectancy

New analysis finds global improvements in life expectancy

Global life expectancy increased by 5.8 years in men and 6.6 years in women between 1990 and 2013, according to a major new analysis from the Global Burden of Disease Study 2013 (GBD 2013). [More]
Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

At the turn of the millennium, the cost to sequence a single human genome exceeded $50 million, and the process took a decade to complete. Microbes have genomes, too, and the first reference genome for a malaria parasite was completed in 2002 at a cost of roughly $15 million. But today researchers can sequence a genome in a single afternoon for just a few thousand dollars. Related technologies make it possible to capture information about all genes in the genome, in all tissues, from multiple individuals. [More]
EGPAF to receive $63 million UNITAID grant to improve early infant diagnosis of HIV programs

EGPAF to receive $63 million UNITAID grant to improve early infant diagnosis of HIV programs

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to announce that it has been selected by the UNITAID Executive Board to receive up to $63 million in funding to improve early infant diagnosis (EID) of HIV programs in nine African countries. This investment will pave the way for universal access to HIV testing and enable a ten-fold increase in HIV treatment, thus transforming the effort to end AIDS in children worldwide. [More]
DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

The Drugs for Neglected Diseases initiative has been awarded US$ 10 million by the United States Agency for International Development to develop new treatments for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) - the first-ever USAID grant for neglected tropical disease research and development (R&D). [More]
NTU scientists discover how malaria parasite develops resistance towards front-line drugs

NTU scientists discover how malaria parasite develops resistance towards front-line drugs

Scientists from Nanyang Technological University have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease. [More]
Study finds that K13 gene mutations cause malaria drug resistance in Southeast Asia

Study finds that K13 gene mutations cause malaria drug resistance in Southeast Asia

Growing resistance to malaria drugs in Southeast Asia is caused by a single mutated gene inside the disease-causing Plasmodium falciparum parasite, according to a study led by David Fidock, PhD, professor of microbiology & immunology and of medical sciences (in medicine) at Columbia University Medical Center. [More]
Scientists report new family of selective molecules to combat causal agent of malaria

Scientists report new family of selective molecules to combat causal agent of malaria

Malaria is one of the most serious health problems worldwide, registering 200 million clinical cases and more than 600,000 attributable deaths per year, according to information from the World Health Organization in 2013. Given the emerging resistance to the standard treatment most widely used throughout the world, which is based on artemisinin and its analogs, there is a need for new antimalarial compounds. [More]
Treatment guidelines lacking for Ebola patients, say infectious diseases experts

Treatment guidelines lacking for Ebola patients, say infectious diseases experts

As the Ebola Virus Diseases (EVD) epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases. [More]
Bed nets alone are enough to protect against malaria, study suggests

Bed nets alone are enough to protect against malaria, study suggests

The combined use of spraying insecticide inside homes and insecticide-treated bed nets is no better at protecting children against malaria than using bed nets alone, a study in The Gambia suggests. The findings, published in The Lancet, should encourage donors to invest their limited resources in additional bed nets, the more cost-effective solution to tackling malaria. [More]

Malaria deaths decline by 54% in Africa, 47% worldwide

The number of people dying from malaria has fallen dramatically since 2000 and malaria cases are also steadily declining, according to the World Malaria Report 2014. Between 2000 and 2013, the malaria mortality rate decreased by 47% worldwide and by 54% in the WHO African Region - where about 90% of malaria deaths occur. [More]
Researchers develop nanomimics of host cell membranes that trick malaria parasites

Researchers develop nanomimics of host cell membranes that trick malaria parasites

Malaria parasites invade human red blood cells, they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. [More]
Promising anti-malarial compound uses novel mechanism to kill malaria parasite

Promising anti-malarial compound uses novel mechanism to kill malaria parasite

An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed. St. Jude Children's Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences. [More]

Melbourne researcher wins Sornchai Looareesuwan Medal for research on malaria

Melbourne researcher Professor Alan Cowman has won the Sornchai Looareesuwan Medal 2014 for his significant contributions to understanding how the malaria parasite causes disease and for his search for potential malaria vaccines. [More]

Scientists uncover potential ammunition in fight against malaria

Scientists have released details of a raft of new chemicals with potent anti-malarial properties which could open the way to new drugs to fight the disease. [More]
Researchers publish first comprehensive characterization of genetic diversity in Sub-Saharan Africa

Researchers publish first comprehensive characterization of genetic diversity in Sub-Saharan Africa

Researchers from the African Genome Variation Project have published the first attempt to comprehensively characterise genetic diversity across Sub-Saharan Africa. The study of the world's most genetically diverse region will provide an invaluable resource for medical researchers and provides insights into population movements over thousands of years of African history. [More]
(RED) raises money for ‘Global Fund to fight AIDS, Tuberculosis and Malaria’

(RED) raises money for ‘Global Fund to fight AIDS, Tuberculosis and Malaria’

As the world reaches a tipping point in the AIDS fight, (RED) and its iconic partners Apple, Bank of America, The Coca-Cola Company and Starbucks marked World AIDS Day 2014 by rallying millions of people around the AIDS fight, and raising money for the Global Fund to fight AIDS, TB and Malaria. [More]
Researchers develop low-cost, electricity-free device for detecting DNA of infectious pathogens

Researchers develop low-cost, electricity-free device for detecting DNA of infectious pathogens

Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers funded by the National Institutes of Health have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1. [More]
Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie. [More]
Health Canada warns Canadians against illegal health products

Health Canada warns Canadians against illegal health products

A vendor in Atlantic Canada (www.health-recovery-info.com) is selling Miracle Mineral Solution (MMS), an unauthorized drug product which Health Canada has previously warned may pose serious risks to health if ingested. [More]